The National Health Regulatory Authority (NHRA) has officially introduced a national traceability program for all medical devices and supplies placed on the Bahraini market. By publishing Circular no (5) 2026 This initiative aims to strengthen regulatory oversight, improve product monitoring, and align Bahrain with international best practices for patient safety.
Who is affected?
The initial phase focuses on the primary entry points of the supply chain:
- Manufacturers.
- Authorized Representatives.
- Wholesalers and other Exporters.
Key Implementation Dates
The program will follow a phased approach to ensure a smooth transition:
- April 2026: Opening of mandatory registration for all targeted stakeholders.
- July 2026: Official launch of the NHRA Traceability Platform and commencement of regulatory requirements.